Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles
Source abstract
Abstract
The ability of nano- and microparticles of partially oxidized mesoporous silicon (pSi) to sequester, protect, and deliver the anthelmintic pore-forming protein Cry5B to nematodes is assessed in vitro and in vivo. Thermally oxidized pSi particles are stable under gastric conditions and show relatively low toxicity to nematodes. Fluorescence images of rhodamine-labeled pSi particles within the nematodes Caenorhabditis elegans and Ancylostoma ceylanicum show that ingestion is dependent on particle size: particles of a 0.4 ± 0.2 μm size are noticeably ingested by both species within 2 h of introduction in vitro, whereas 5 ± 2 μm particles are excluded from C. elegans but enter the pharynx region of A. ceylanicum after 24 h. The anthelmintic protein Cry5B, a pore-forming crystal (Cry) protein derived from Bacillus thuringiensis, is incorporated into the pSi particles by aqueous infiltration. Feeding of Cry5B-loaded pSi particles to C. elegans leads to significant intoxication of the nematode. Protein-loaded particles of size 0.4 μm display the highest level of in vitro toxicity toward C. elegans on a drug-mass basis. The porous nanostructure protects Cry5B from hydrolytic and enzymatic (pepsin) degradation in simulated gastric fluid (pH 1.2) for time periods up to 2 h. In vivo experiments with hookworm-infected hamsters show no significant reduction in worm burden with the Cry5B-loaded particles, which is attributed to slow release of the protein from the particles and/or short residence time of the particles in the duodenum of the animal.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Insect Resistance and Genetics · Nematode management and characterization studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Materials Science and Engineering, ‡Section of Cell and Development Biology, and §Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States
Funding
National Institute of Allergy and Infectious Diseases · Division of Materials Research · Defense Advanced Research Projects Agency
References (61)
Show source-provided references
1. Ojha S. C. · J. Infect. Dev. Countries · 2014 · 8 · 00510.3855/jidc.3183 ↗
2. Bleakley H. · Q. J. Econ. · 2007 · 122 · 7310.1162/qjec.121.1.73 ↗
3. Humphries D. · Am. J. Trop. Med. Hyg. · 2013 · 89 · 54010.4269/ajtmh.12-0605 ↗
4. Geary T. G. · Curr. Opin. Infect. Dis. · 2012 · 25 · 70910.1097/QCO.0b013e328359f04a ↗
5. Whalon M. E. · Arch. Insect Biochem. Physiol. · 2003 · 54 · 20010.1002/arch.10117 ↗
6. Urban J. F. J. · PLoS Neglected Trop. Dis. · 2013 · 7 · e226310.1371/journal.pntd.0002263 ↗
7. Hu Y. · Invertebr. Neurosci. · 2012 · 12 · 3710.1007/s10158-012-0135-8 ↗
8. Hu Y. · 2012 · 26710.1002/9783527652969.ch16 ↗
9. Canham L. T. · Adv. Mater. · 1995 · 7 · 103310.1002/adma.19950071215 ↗
10. Anderson S. H. C. · Phys. Status Solidi A · 2003 · 197 · 33110.1002/pssa.200306519 ↗
11. Low S. P. · Biomaterials · 2009 · 30 · 287310.1016/j.biomaterials.2009.02.008 ↗
12. Canham L. T. · Phys. Status Solidi A · 2000 · 182 · 52110.1002/1521-396X(200011)182:1<521::AID-PSSA521>3.0.CO;2-7 ↗
13. Anglin E. J. · Adv. Drug Delivery Rev. · 2008 · 60 · 126610.1016/j.addr.2008.03.017 ↗
14. Salonen J. · J. Pharm. Sci. · 2008 · 97 · 63210.1002/jps.20999 ↗
15. 10.1895/wormbook.1.143.110.1895/wormbook.1.143.1 ↗
16. Xia L.-Q. · J. Mol. Model · 2008 · 14 · 84310.1007/s00894-008-0318-8 ↗
17. Hui F. · Biochemistry · 2012 · 51 · 991110.1021/bi301386q ↗
18. Collins B. E. · Adv. Funct. Mater. · 2002 · 12 · 18710.1002/1616-3028(200203)12:3<187::AID-ADFM187>3.0.CO;2-E ↗
19. Karlsson L. M. · Thin Solid Films · 2004 · 455 · 72610.1016/j.tsf.2004.01.062 ↗
20. DeLouise L. A. · Anal. Chem. · 2005 · 77 · 322210.1021/ac048144+ ↗
21. Park J. S. · J. Microbiol. Biotechnol. · 2006 · 16 · 1968
22. Orosco M. M. · Nat. Nanotechnol. · 2009 · 4 · 25510.1038/nnano.2009.11 ↗
23. Andrew J. S. · Adv. Funct. Mater. · 2010 · 20 · 416810.1002/adfm.201000907 ↗
24. Chen M. Y. · Adv. Mater. · 2011 · 23 · 453710.1002/adma.201102090 ↗
25. Prestidge C. A. · Phys. Status Solidi A · 2007 · 204 · 336110.1002/pssa.200723112 ↗
26. De Stefano L. · J. Phys.: Condens. Matter · 2007 · 19 · 395009
27. Tay L. · J. Vac. Sci. Technol., A · 2006 · 24 · 74710.1116/1.2192525 ↗
28. DeLouise L. A. · Anal. Chem. · 2005 · 77 · 195010.1021/ac0486185 ↗
29. Foraker A. B. · Pharm. Res. · 2003 · 20 · 11010.1023/A:1022211127890 ↗
30. Arwin H. · Phys. Status Solidi A · 2000 · 182 · 51510.1002/1521-396X(200011)182:1<515::AID-PSSA515>3.0.CO;2-W ↗
31. Zangooie S. · Thin Solid Films · 1998 · 313 · 82510.1016/S0040-6090(97)01003-1 ↗
32. Chen M. Y. · Anal. Chem. · 2011 · 83 · 718610.1021/ac201636n ↗
33. Sailor, M. J.Porous Silicon in Practice: Preparation, Characterization, and Applications;Wiley-VCH:Weinheim, Germany, 2012; p249.10.1002/9783527641901 ↗
34. Canham L. T. · Nanotechnology · 2007 · 18 · 18570410.1088/0957-4484/18/18/185704 ↗
35. Wu E. C. · Chem. Commun. · 2011 · 47 · 569910.1039/c1cc10993f ↗
36. Park J.-H. · Nat. Mater. · 2009 · 8 · 33110.1038/nmat2398 ↗
37. Cheng L. · Br. J. Ophthalmol. · 2008 · 92 · 70510.1136/bjo.2007.133587 ↗
38. Schwartz M. P. · Langmuir · 2006 · 22 · 708410.1021/la060420n ↗
39. Mayne A. H. · Phys. Status Solidi A · 2000 · 182 · 50510.1002/1521-396X(200011)182:1<505::AID-PSSA505>3.0.CO;2-# ↗
40. Bayliss S. C. · J. Porous Mater. · 2000 · 7 · 19110.1023/A:1009686704506 ↗
41. Canham, L. T.Porous silicon as a therapeutic biomaterial. InProceedings of 1st Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Medicine and Biology, Lyon, France, October 12–14, 2000; pp109–112.10.1109/MMB.2000.893752 ↗
42. Schwartz M. P. · Phys. Status Solidi A · 2007 · 204 · 144410.1002/pssa.200674380 ↗
43. Bonanno L. M. · Langmuir · 2007 · 23 · 581710.1021/la063659c ↗
44. Tsargorodskaya A. · Nanotechnology · 2004 · 15 · 70310.1088/0957-4484/15/5/051 ↗
45. Wu E. C. · Biomaterials · 2011 · 32 · 195710.1016/j.biomaterials.2010.11.013 ↗
46. Clokey G. V. · Mech. Ageing Dev. · 1986 · 35 · 7910.1016/0047-6374(86)90068-0 ↗
47. Pluskota A. · PLoS One · 2009 · 4 · e662210.1371/journal.pone.0006622 ↗
48. Inpankaew T. · Emerging Infect. Dis. · 2014 · 20 · 97610.3201/eid2006.131770 ↗
49. Hu Y. · PLoS Neglected Trop. Dis. · 2012 · 6 · e190010.1371/journal.pntd.0001900 ↗
50. Hu Y. · PLoS One · 2013 · 8 · e7070210.1371/journal.pone.0070702 ↗
51. Weitschies W. · Adv. Drug Delivery Rev. · 2005 · 57 · 121010.1016/j.addr.2005.01.025 ↗
52. Ponchel G. · Adv. Drug Delivery Rev. · 1998 · 34 · 19110.1016/S0169-409X(98)00040-4 ↗
53. Cappello M. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 1515410.1073/pnas.0607002103 ↗
54. Griffitts J. S. · Science · 2001 · 293 · 86010.1126/science.1062441 ↗
55. Qin Z. · Part. Part. Syst. Charact. · 2014 · 31 · 25210.1002/ppsc.201300244 ↗
56. Bimbo L. M. · ACS Nano · 2010 · 4 · 302310.1021/nn901657w ↗
57. Meade S. O. · Anal. Chem. · 2009 · 81 · 261810.1021/ac802538x ↗
58. Hu Y. · PLoS Neglected Trop. Dis. · 2009 · 3 · e49910.1371/journal.pntd.0000499 ↗
59. Hu Y. · PLoS Neglected Trop. Dis. · 2010 · 4 · e61410.1371/journal.pntd.0000614 ↗
60. Bischof L. J. · 2006 · 351 · 13910.1385/1-59745-151-7:139 ↗
61. Kao C. Y. · PLoS Pathog. · 2011 · 7 · 17